• The US Supreme Court ruled 7-2 to block thousands of lawsuits against Bayer regarding Roundup's cancer warnings.
• The decision supports Bayer's position that federal regulations preempt state-level failure-to-warn claims.
• Over 100,000 lawsuits have been filed against Bayer, following allegations linking glyphosate to cancer.
• The ruling is considered a legal victory for Bayer and the Trump administration amid ongoing litigation challenges.
• Critics argue the ruling undermines public health considerations and could leave many plaintiffs without recourse.

The US Supreme Court has issued a significant ruling, blocking thousands of lawsuits aimed at Bayer over the alleged cancer risks of its Roundup weedkiller. In a 7-2 decision, the court concluded that federal regulations, which do not require a cancer warning on glyphosate, preempt state-level failure-to-warn claims. This ruling came in a case involving John Durnell, a Missouri resident who developed non-Hodgkin lymphoma after using Roundup extensively for weed control. His jury verdict of $1.25 million was overturned by this ruling, emphasizing Bayer's argument that U.S. pesticide laws govern such cases, according to Reuters, Los Angeles Times, and Al Jazeera.

This ruling, described by Bayer as a validation of scientific consensus, could potentially dismiss many pending lawsuits alleging wrongful failure to warn users of Roundup's cancer risks. Bayer's spokesperson stated, "The ruling should help significantly contain the Roundup litigation after nearly a decade of legal battles." In support of this decision, the court cited findings by the Environmental Protection Agency (EPA) that glyphosate is unlikely to cause cancer, reinforcing Bayer's position that it is not required to include such warnings on product labels, according to Reuters, Los Angeles Times, and Al Jazeera.

The Supreme Court's decision comes amidst widespread litigation against Bayer, with more than 100,000 plaintiffs alleging a cancer link to Roundup. This legal clash intensified following Bayer’s acquisition of Monsanto in 2018. Notably, corporate shares surged nearly 18% after the ruling was announced, reflecting investor optimism about Bayer's legal prospects. However, a significant settlement proposal of $7.25 billion is still on the table to resolve numerous ongoing claims. Critics of the court's decision maintain that it closes off legal avenues for plaintiffs and undermines public health, warning that the ruling is a "disaster for public health" and could perpetuate chronic health issues among affected populations, according to Reuters, Los Angeles Times, and Al Jazeera.

The ruling relies heavily on provisions of the Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA), indicating that state laws cannot impose additional requirements beyond federal standards. Justice Brett Kavanaugh, delivering the majority opinion, stressed that the claims made by Durnell would improperly impose state requirements contrary to federal law. The dissent, articulated by Justices Ketanji Brown Jackson and Neil Gorsuch, argued that the ruling unjustly prevents state courts from addressing consumer protection in cases like Durnell’s, according to Reuters, Los Angeles Times, and Al Jazeera.